# Prevention of Unexplained Recurrent Abortion by Enoxaparine

> **NCT00740545** · PHASE3 · TERMINATED · sponsor: **University Hospital, Brest** · enrollment: 258 (actual)

## Conditions studied

- Alive and Viable Births

## Interventions

- **DRUG:** enoxaparine 40 mg daily
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00740545
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-04
- **Primary completion:** 2013-09
- **Final completion:** 2014-09
- **Target enrollment:** 258 (ACTUAL)
- **Why stopped:** Stopped for futility
- **Last updated:** 2015-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00740545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00740545, "Prevention of Unexplained Recurrent Abortion by Enoxaparine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00740545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*